12th International Heidelberg Symposium on Stem Cells and Cancer

The 12th Edition of the “International Heidelberg Symposium on Stem Cells and Cancer” (SCC2025) will once again host world-leading experts at the German Cancer Research Center (DKFZ) for an exceptional symposium showcasing the latest breakthroughs in cancer biology and therapy. This event brings together a vibrant mix of topics spanning malignant stem cell plasticity, tumor heterogeneity, therapy resistance mechanisms, tumor metabolism, Tumor microenvironment, synthetic immunology, circulating tumor cells, and metastasis. The program highlights cutting-edge therapeutic innovations across a spectrum of malignancies, including acute leukemias, breast, colon, pancreatic, skin, and brain cancers.

Confirmed Keynote Speakers:

• Andrew Wei (Melbourne)
• Elaine Fuchs (New York)
• Scott Armstrong (Boston)

Featured International Faculty:

Fred de Sauvage (Genentech), Peggy Goodell (Houston), Ross Levine (NY), Catriona Jamieson (San Diego), Sarah-Maria Fendt (Leuven), Cedric Blanpain (Brussels), Salvador Aznar-Benitah (Barcelona), Nina Cabezas-Wallscheid (Zürich), Elisa Laurenti (Cambridge), Ann-Kathrin Eisfeld (Columbus), Paresh Vyas (Oxford)

...alongside leading national and local scientists (see full program/poster attached).

What to Expect:

• Exclusive content: No recordings—speakers will present unpublished, cutting-edge data.
• Dynamic exchange: A medium-sized format ensures close interaction and discussion with global thought leaders.
• Active participation: Share your work in the poster session or be selected for a short talk from submitted abstracts.

Deadline for abstract submission: poster and short oral presentations (selected from abstracts): Monday July 7th 2025.
Deadline for participation registration: Sunday August 10th (will be closed, as soon as capacity for the DKFZ lecture hall is reached).

Registration